LaFerla FM - Search Results

1

Formulation of a medical food cocktail for Alzheimer's disease: beneficial effects on cognition and neuropathology in a mouse model of the disease.

Parachikova A, Green KN, Hendrix C, LaFerla FM. Parachikova A, et al. Among authors: laferla fm. PLoS One. 2010 Nov 17;5(11):e14015. doi: 10.1371/journal.pone.0014015. PLoS One. 2010. PMID: 21103342 Free PMC article.

2

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Oddo S, et al. Among authors: laferla fm. Neuron. 2003 Jul 31;39(3):409-21. doi: 10.1016/s0896-6273(03)00434-3. Neuron. 2003. PMID: 12895417 Free article.

3

Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Oddo S, et al. Among authors: laferla fm. Neurobiol Aging. 2003 Dec;24(8):1063-70. doi: 10.1016/j.neurobiolaging.2003.08.012. Neurobiol Aging. 2003. PMID: 14643377

4

Presenilin regulates capacitative calcium entry dependently and independently of gamma-secretase activity.

Akbari Y, Hitt BD, Murphy MP, Dagher NN, Tseng BP, Green KN, Golde TE, LaFerla FM. Akbari Y, et al. Among authors: laferla fm. Biochem Biophys Res Commun. 2004 Oct 1;322(4):1145-52. doi: 10.1016/j.bbrc.2004.07.136. Biochem Biophys Res Commun. 2004. PMID: 15336962

5

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease.

Oddo S, Caccamo A, Green KN, Liang K, Tran L, Chen Y, Leslie FM, LaFerla FM. Oddo S, et al. Among authors: laferla fm. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3046-51. doi: 10.1073/pnas.0408500102. Epub 2005 Feb 10. Proc Natl Acad Sci U S A. 2005. PMID: 15705720 Free PMC article.

6

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Billings LM, et al. Among authors: laferla fm. Neuron. 2005 Mar 3;45(5):675-88. doi: 10.1016/j.neuron.2005.01.040. Neuron. 2005. PMID: 15748844 Free article.

7

Alzheimer's disease: Abeta, tau and synaptic dysfunction.

LaFerla FM, Oddo S. LaFerla FM, et al. Trends Mol Med. 2005 Apr;11(4):170-6. doi: 10.1016/j.molmed.2005.02.009. Trends Mol Med. 2005. PMID: 15823755 Review.

8

Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals.

Smith IF, Green KN, LaFerla FM. Smith IF, et al. Among authors: laferla fm. Cell Calcium. 2005 Sep-Oct;38(3-4):427-37. doi: 10.1016/j.ceca.2005.06.021. Cell Calcium. 2005. PMID: 16125228 Review.

9

Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.

Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM. Smith IF, et al. Among authors: laferla fm. J Neurochem. 2005 Sep;94(6):1711-8. doi: 10.1111/j.1471-4159.2005.03332.x. J Neurochem. 2005. PMID: 16156741 Free article.

10

Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.

Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Kitazawa M, et al. Among authors: laferla fm. J Neurosci. 2005 Sep 28;25(39):8843-53. doi: 10.1523/JNEUROSCI.2868-05.2005. J Neurosci. 2005. PMID: 16192374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters